1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
29.17%
Revenue growth above 1.5x 6617.T's 18.14%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
41.38%
Gross profit growth at 50-75% of 6617.T's 63.93%. Martin Whitman would question if cost structure or brand is lagging.
473.50%
EBIT growth above 1.5x 6617.T's 136.52%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
226.92%
Operating income growth above 1.5x 6617.T's 127.93%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2675.78%
Net income growth above 1.5x 6617.T's 136.36%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2573.08%
EPS growth above 1.5x 6617.T's 136.38%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2573.08%
Diluted EPS growth above 1.5x 6617.T's 136.38%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Reduced diluted shares while 6617.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-82.54%
Negative 10Y revenue/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-82.54%
Negative 5Y CAGR while 6617.T stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
76.60%
3Y CAGR of 76.60% while 6617.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
100.00%
3Y OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
105.52%
10Y net income/share CAGR of 105.52% while 6617.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
105.52%
Net income/share CAGR of 105.52% while 6617.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
275.63%
3Y net income/share CAGR of 275.63% while 6617.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
201.71%
Positive short-term equity growth while 6617.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.87%
AR growth well above 6617.T's 26.56%. Michael Burry fears inflated revenue or higher default risk in the near future.
-20.65%
Inventory is declining while 6617.T stands at 10.85%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-18.90%
Negative asset growth while 6617.T invests at 8.42%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.76%
BV/share growth above 1.5x 6617.T's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-23.41%
We’re deleveraging while 6617.T stands at 27.30%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
4.08%
We expand SG&A while 6617.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.